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Abstract
Ultrasounds and ionizing radiation are extensively used for diagnostic applications in the cardiology
clinical practice. This paper reviewed the available information on occupational risk of the
cardiologists who perform, every day, cardiac imaging procedures. At the moment, there are no
consistent evidence that exposure to medical ultrasound is capable of inducing genetic effects, and
representing a serious health hazard for clinical staff. In contrast, exposure to ionizing radiation may
result in adverse health effect on clinical cardiologists. Although the current risk estimates are
clouded by approximations and extrapolations, most data from cytogenetic studies have reported
a detrimental effect on somatic DNA of professionally exposed personnel to chronic low doses of
ionizing radiation. Since interventional cardiologists and electro-physiologists have the highest
radiation exposure among health professionals, a major awareness is crucial for improving
occupational protection. Furthermore, the use of a biological dosimeter could be a reliable tool for
the risk quantification on an individual basis.
Introduction
Over the last 30 years, medical cardiology imaging has
rapidly grown, becoming an essential part of the cardiol-
ogy clinical practice. Imaging procedures include conven-
tional imaging tests such as echocardiography,
radionuclide imaging, and angiography as well as a newer
imaging techniques such as emission computed tomogra-
phy and magnetic resonance imaging which promise to
expand diagnostic capabilities [1]. These techniques
widely differ not only for what concerns costs, availability
and technical information, but they also differ in environ-
mental and health hazards.
Many cardiac procedures can deliver high radiation doses
to the clinical staff [2]. This exposure may represent a sig-
nificant health risk, resulting in deleterious clinical impli-
cations which can affect not only the personnel involved,
but also their progeny [3-5]. Unfortunately, many physi-
cians are unfamiliar with radiation biology or the quanti-
tative nature of the risks and, frequently, ultrasound and
ionizing radiation risks are misunderstood [6-9]. The pur-
pose of this paper is to discuss the published evidence on
health effects of cardiac imaging procedures employing
ultrasound and ionizing radiation.
Ultrasound imaging
Ultrasound imaging, also called sonography, is a method
of obtaining human body images through the use of high
frequency sound waves. Ultrasounds are mechanical
vibrations with frequencies above the human limit of
audibility. The use of ultrasounds in order to obtain
images for medical diagnostic purposes, typically employs
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frequencies ranging from 2 MHz to about 12 MHz [10].
Ultrasound does not use ionizing radiation, and it is the
preferred image modality for monitoring both pregnant
women and their embryos or fetus [10]. In contrast to ion-
izing radiation, which can damage biological materials by
dislodging electrons from atoms and molecules, ultra-
sounds do not cause ionisation. They usually interact with
human tissue primarily by generating heat, but also non-
thermal effects which are ascribed to cavitation (i.e.
micro-bubble) [11]. The process of cavitation includes
ultrasounds mechanical effects which lead to hydrody-
namic breaks of hydrogen bonds and oscillation of hydro-
gen ions, and chemical effects produced by the occurrence
of free radicals in intercarionic space in the process of cav-
itation (Figure 1). Theoretically, these free radicals may
interfere with DNA, causing chromosomal damage.
Indeed, ultrasounds of diagnostic intensities induced
detectable DNA damage in animal cells [12,13]. Cur-
rently, there is a body of studies on human DNA damage
from exposure to therapeutic and diagnostic ultrasounds
[14-20]. In particular, Stella et al. [15] reported that ther-
apeutic ultrasound induce a significant increase in sister
chromatid exchanges (SCEs) in human lymphocytes after
treatment both in vitro and in vivo. In the same study, no
increase in chromosomal aberrations was observed dur-
ing and after ultrasound therapy [15]. Subsequently, some
reports on human cells indicated that ultrasound was not
able to induce SCEs or chromosomal damage (Table 1).
Thus, there is at present no indication that exposure to
medical ultrasound is capable of inducing genetic effects
At high acoustic pressure, ultrasound is capable of causing rapid bubble which grow and collapse among them (a) and cells (b) Figure 1
At high acoustic pressure, ultrasound is capable of causing rapid bubble which grow and collapse among them (a) and cells (b). 
This mechanism results in the production of sufficient energy to disrupt chemical bonds and produce reactive free radicals, that 
may interfere with DNA.
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and representing a serious health hazard for clinical staff.
However, very little information is available on the
genetic effects of individuals occupationally exposed to
chronic ultrasound. Medical staff can be exposed to hand-
transmitted ultrasound waves in the work-place.
Indeed, ultrasound sources do not transmit acoustic
energy into air, and only low level ultrasound reaches
medical personnel through handling of the probe [21].
Probably, occupational exposure to ultrasound occurs
during training procedures [21]. In fact, medical person-
nel often apply diagnostic ultrasound to themselves dur-
ing training or during technique demonstrations [21].
Consequently, ultrasound is not harmful like the other
types and sources of radiation. However, a recent investi-
gation indicated that medical personnel from a cardiology
unit working with colour Doppler ultrasonic equipment
had an increased genotoxic damage compared to the con-
trol subjects [22]. Therefore, this observation requires fur-
ther studies in order to determine if chronic exposure to
ultrasound might induce genotoxic effects.
Ionizing radiation
Ionizing radiation is known to cause harm. High radia-
tion doses tend to kill cells, while low doses tend to dam-
age or alter the genetic code (DNA) of irradiated cells. The
biological effects of ionizing radiation are divided into
two categories: deterministic and stochastic effects. Deter-
ministic effects, such as erythema or cataract, have a thresh-
old dose below which the biological response is not
observed [23-25]. Some interventional procedures with
long screening times and multiple image acquisition (e.g.
percutaneous coronary intervention, radio-frequency
ablation, etc) may give rise to deterministic effects in both
staff and patients [26,27].
A stochastic effect is a probabilistic event and there is no
known threshold dose. The likelihood of inducing the
effect, but not the severity, increases in relation to dose
and may differ among individuals.
In fact, the effect of low doses of radiation -less than 50
mSv- do not cause an immediate problem to any body
organ, but spread out over long periods of time after
exposure. The biological effects are at DNA level and they
may not be detected [23-25]. The cell has repair mecha-
nisms against damage induced by radiation as well as by
chemical carcinogens. Consequently, biological effects of
low dose radiation on living cells may result in three out-
comes: (1) injured or damaged cells repair themselves,
resulting in no residual damage; (2) cells die; or (3) cells
incorrectly repair themselves resulting in a biological
change (Figure 2). Such biological changes include the
development of cancer and genetic defects in the future
children of exposed parents. At present, however, the
effects of low-level exposure remain uncertain [28]. The
associations between radiation exposure and the develop-
ment of cancer are mostly based on populations exposed
Table 1: Summary of studies on genetic effects of medical ultrasounds
Author, Year (Ref) Assay System Endpoint Exposure Result
Miller et al., 1983 (14) Human lymphocytes exposed in 
vitro
SCE 2 MHz
SPPA intensity 100 W/cm2
Negative
Stella et al., 1984 (15) Human lymphocytes exposed in 
vitro
SCE
CA
1 W/cm2; 0.860 MHz; for 40–160 sec Positive/ Negative
Barnett et al., 1987 (16) Human lymphocytes exposed in 
vitro
SCE 3.1 MHz
SPPA intensities from 15 to 135 W/
cm2.
Negative
Carrera P et al., 1990 (17) Chorionic villi exposed in vitro
Chorionic villi from exposed 
pregnant women
SCE 2 MHz at 1, 2, 3 h
Diagnostic US for 20 min (in vivo 
exposure
Negative
Miller et al., 1991 (18) Human lymphocytes from 
exposed patients
SCE 4 patients underwent therapeutic US
4 healthy persons underwent sham-
therapeutic US
Negative
Martini et al., 1991 (19) Lymphocyte and lymphoblastoid 
cells exposed in vitro
SCE 5 MHz for 20 sec, 1 min, 5 min, and 
20 min
Negative
Sahin O et al., 2004 (20) Human lymphocytes from 
exposed patients
MN 10 patients underwent 10 session of 
US therapy at 1 MHz for 10 min and 
10 control subjects underwent sham-
therapeutic US
Negative
Garaj-Vrhovac and Kopjar, 2000 (22) Human lymphocytes from 
cardiologists working with 
Doppler ultrasound
CA
SCE
MN
Unit working with colour Doppler US 
(transducer frequencies 2.5–7.5 MHz.
SPPA intensity 60–110 W/cm2.
Positive
SCE: sister-chromatid exchange; MN: Micronuclei; CA: Chromosomal aberrations; SPPA: Spatial Peak Pulse AverageCardiovascular Ultrasound 2004, 2:25 http://www.cardiovascularultrasound.com/content/2/1/25
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to relatively high levels of ionizing radiation (e.g., Japa-
nese atomic bomb survivors). Since extraordinary large
studies are required to quantify the risks of very low doses
of radiation, it is unlikely that we will be able to precisely
quantify cancer risk in human populations at doses below
10 mSv [28]. For instance, an epidemiological study of
more than 5 million people would be needed to quantify
the effect for a 10 -mSv dose or less [28]. Our inability to
quantify risk does not, however, imply that this risk is neg-
ligible. Furthermore, the small (and often not so small)
individual risk applied to a large number of individuals,
and by protracted exposures, translates into a significant
public health problem). As such, the international scien-
tific community has adopted a prudent approach and
acknowledged the fact that any level of exposure could
potentially lead to biological effects. A linear, no-thresh-
old dose response relationship is used by the IRCP in
order to describe the relationship between radiation dose
and the occurrence of cancer [29]. This dose-response
model suggests that any increase in dose, no matter how
small, results in an incremental increase in risk.
Genetic effects are the result of a mutation produced in
the reproductive cells of an exposed individual that are
passed on to their offspring. These effects may show up as
birth defects or other conditions in the future children of
the exposed individual and succeeding generation.
Indeed, studies with laboratory animals have provided a
large body of data on radiation-induced genetic effects
[30]. Recently, these effects have been also observed in
Radiation damage of DNA Figure 2
Radiation damage of DNA. Damaged DNA is screened through the process of DNA repair and mismatch correction. DNA 
lesions that escape repair, has the ability to produce mutations, which lead to the development and the progression of both 
cancer and human diseases even decades after exposure.
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studies of people exposed to radiation from Chernobyl
disaster, radiation workers and medical radiologists who
have received doses of radiation [31-33]. However, no
conclusive evidence exists yet [34,35].
Radiation exposure to cardiologists
The use of radiation in medicine is the largest source of
man-made radiation exposure. According to the latest
estimation of the United Nations, an average of 2.4 mSv/
year comes from natural sources [24]. In western coun-
tries, the exposure dose from medical radiation corre-
sponds to 50 to 100% of the total natural radiation. In
1997, the German Federal Office for Radiation Protection
reported 136 million x ray examinations and 4 million
nuclear medicine diagnostic tests, resulting in a mean
effective dose of 2.15 mSv per person per year [36]. Car-
diac and interventional procedures account for a large per-
centage of nuclear and radiological examinations [36]. Of
all radiological examinations, 28% are arteriographies
and interventions. An additional 2% derive from chest X-
rays and 37% from CT: many of them are cardiological
referrals. Regarding nuclear medicine, 22% are
cardiological scan. These percentages are likely higher
now, since the use of cardiac and interventional proce-
dures is increasing.
Cardiac ionizing procedures expose both patients and
medical staff to the highest radiation levels in diagnostic
radiology, and recently, as the number of diagnostic and
interventional cardiac catheterisation procedures has
greatly increased, serious radiation induced skin injuries
and an excess of cataract development have been reported
in exposed staff [37-39]. Furthermore, it has been sug-
gested that fluoroscopic procedures may be a health haz-
ard and increase the risk for brain tumours in
interventional cardiologists [40].
Today, interventional cardiologists represent, indeed, the
most important group of exposed among professionally
exposed physicians [41,42].
As known, the limit on effective dose for exposed workers
should be 100 mSv in a consecutive five year period, sub-
ject to a maximum effective dose of 50 mSv in any single
year. Radiation dose limits to adult occupational workers
provided by the International Commission on Radiologi-
cal Protection (ICRP) are shown in table 2.
As a matter of fact, the head dose sustained by cardiolo-
gists may reach 60 mSv per year, and may in some cases
exceed the occupational limit of 150 mSv per year recom-
mended for the lens of the eye [41].
However, the correlation between occupational doses and
staff radiological risks is not simple, and it is very depend-
ent on equipment, the specialist, and protocols followed
throughout the procedure [43]. Many factors can influ-
ence occupational doses for the same radiation dose
imparted during cardiac procedure. One of the most
important factors is that protection tools are available in
catheterisation laboratories and are appropriately used
[43]. In addition, another likely reason is a lack of knowl-
edge, information and training in radiation protection
[43].
Importantly, a recent survey showed that that most of car-
diologists do not correctly evaluate the dose exposure, the
medico-legal regulation, the environmental impact and
individual bio-risks of the radiological investigations [9].
As shown in table 3, this surprising lack of knowledge of
both dose and clinical risk of commonly performed ionis-
ing test examinations, is not at all restricted to cardiolo-
gists, and seems to be democratically spread across all
specialties – from surgeons to orthopaedics, to paediatri-
cians [6-9].
Probably, this unawareness has its root in the difficult per-
ception of a long-term risk associated to radiation expo-
sure. In particular, the perception of cancer risk, which can
have a latency period of many years after exposure, is
often elusive. Furthermore, the exact risk at very low doses
to a specific individual is further complicated by many
Table 2: Recommended occupational dose limits by International Commission on Radiological Protection (ICRP).
TISSUE INJURY OCCUPATIONAL DOSE LIMITS/YEAR
whole body 20 mSv 2 rem
Lens of the eye 150 mSv 15 rem
Skin, hands, feet, and other organs 500 mSv 50 remCardiovascular Ultrasound 2004, 2:25 http://www.cardiovascularultrasound.com/content/2/1/25
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factors, such as carcinogenic agents in our environment,
cigarette smoke, diet and genetic background.
However, a recent study has estimated that from 0.6% to
3% of all cancers are due to medical X-rays [44]. These fig-
ures are impressive but may largely underestimate the true
risk, since they are referred to radiological data concerning
the 1991–1996. Taking into account current radiological
activities, medical radiation is likely to account for at least
20% of cancer in developed countries [45].
With regard to occupational exposure for radiologists and
radiotherapists, available epidemiological studies have
been recently reviewed by Yoshinaga et al [46]. An excess
risk of leukaemia associated with occupational radiation
was found among early workers employed before 1950,
when radiation exposures were high. In addition, several
studies provided evidence of a radiation effect for breast
and skin cancer. To date, there is no clear evidence of an
increased cancer risk in medical radiation workers
exposed to current levels of radiation doses. However,
given a relatively short period of time for which the most
recent workers have been followed up and in view of the
increasing uses of radiation in modern medical practices,
it is important to continue to monitor the health status of
medical radiation workers [46].
To the fatal cancer risk, one must add the risk of non-fatal
cancer and major genetic damage transmitted to the off-
spring. It is relevant to underline that the long-term dam-
age may not include only cancer but also other major
degenerative diseases, including atherosclerosis [47,48].
However, it is important to realize that many difficulties
are involved in designing epidemiological studies that can
accurately measure the increases in health effects due to
low exposures to radiation as compared to the normal rate
of cancer. Studies with very large sample size are required
in order to quantify the risks of very low doses of radia-
tion. An alternative strategy could be based on the
measure of biological effects by using biomarkers as predic-
tors of delayed health outcomes [49].
Biomarkers in the assessment of radiation 
exposure
Damage to deoxyribonucleic acid (DNA), which carries
the genetic information in chromosomes in the cell
nucleus, is considered to be the main initiating event by
which radiation damage to cells results in the develop-
ment of cancer and hereditary disease. Four biomarkers
(Figure 3) -analysis of structural chromosome aberrations,
micronucleus assay, sister chromatid exchange analysis
and comet assay- in peripheral lymphocytes are currently
employed in order to study human exposure to environ-
mental carcinogens [50]. Among these, the test of chro-
mosomal aberrations in peripheral blood lymphocytes
has the most abundant literature validating that a high fre-
quency of chromosomal breakage is a strong predictor of
cancer risk in healthy subjects [51,52].
Table 3: Doctors' knowledge of radiation dose and risk for medical ionising testing
Author, year (Ref) Physicians Radiological Awareness 
Evaluation
Results
Shiralkar S et al., 2003 (6) British physicians Radiation doses for common 
radiological investigations.
97% of doctors underestimates dose.
5% believes that US use ionising 
radiation.
8% believes thatMRI use ionising 
radiation.
Finestone A et al., 2003 (7) Istraeli orthopaedists Mortality risk of radiation-induced 
carcinoma from bone scan 
scintigraphy
Mortality risk was identified correctly 
by less than 5% of respondents.
Lee CI et al., 2004 (8) Emergency department (ED), 
physicians and radiologists
Radiation dose and possible risks 
associated with CT scan
Almost all doctors were unable to 
accurately estimate the dose.
Only 9% ED physicians believed that 
there was increased risk.
Correia MJ et al., 2005 (9) Adult and paediatric cardiologists Environmental impact, individual bio-
risks, dose exposure and medico-legal 
regulation of medical ionising testing
Only 11%, 5%, 29% and 42% of 
physicians correctly identified 
environmental impact, individual bio-
risks, dose exposure and legal 
regulation, respectively.
CT = computed tomography; MRI = magnetic resonance imaging; US = ultrasoundCardiovascular Ultrasound 2004, 2:25 http://www.cardiovascularultrasound.com/content/2/1/25
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During the last years, the micronucleus assay has become
popular since it is fast and inexpensive, and it is consid-
ered to be a "biological dosimeter" for exposure to ioniz-
ing radiation [53].
The importance of cytogenetic study of peripheral lym-
phocytes in subjects exposed to ionizing radiation has
been reported for more than 20 years, especially in radiol-
ogists [54-68]. The available evidence suggests that
chronic exposure to low dose radiation has a genotoxic
effect on somatic DNA of professionally exposed workers
(Table 4). This effect seems to be cumulative over time,
although the majority of these studies failed to establish a
dose-effect relationship for low doses. The absence of
increase of somatic DNA damage in relation to the dose
might be explained by various factors. Dosimetry records
Biomarkers of DNA damage in human lymphocytes Figure 3
Biomarkers of DNA damage in human lymphocytes: a) Structural chromosomal aberrations (CA) are typical of cancer cells, 
probably as a manifestation of genetic instability. b) Micronuclei (MN) can originate from chromosome breaks or whole chro-
mosomes that fail to engage with the mitotic spindle when the cell divides. Therefore, the micronucleus test can be considered 
just as a real "biological dosimeter" for evaluating both numerical and structural chromosome aberrations. c) Sister chromatid 
exchanges (SCEs) represent symmetrical exchanges between sister chromatids; generally they do not result in chromosomal 
alterations of the genetic information. c) The Comet assay is an especially sensitive method for detecting DNA single-strand 
breaks and oxidative DNA damage in individual cells. The entity of the DNA damage is proportional to the length of the 
comet.
Metaphase with dicentric chromosome
Binucleated cells with MN
a)
b)
c)
d)
Metaphase with SCEs
Lymphocyte with cometCardiovascular Ultrasound 2004, 2:25 http://www.cardiovascularultrasound.com/content/2/1/25
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may underestimate the real dose exposure if the badges
are not properly worn. The potential combined effect of
other genotoxic exposures would also induce DNA dam-
age, enhancing the effect of radiation exposure [63].
Moreover, genetic susceptibility may account for the inter-
individual differences to radiation sensitivity. Such possi-
ble susceptibility may recognize sources of variability
(genetic polymorphism) in people's DNA repair gene
sequence [69]. However, it is interesting to underline that,
in a group of radiologists, it has been documented an
important parallelism between the decrease of the expo-
sure to ionizing radiation in the hospitals and a reduction
in the frequency of chromosome aberrations over the
most recent decades [58] (Figure 4). This decrease was the
result of an efficient protection policy among radiologists.
Unfortunately, this is not the case for invasive cardiolo-
gists who need to know very well both the long-term risks
and the doses involved in the large amount of examina-
tions they prescribe and/or perform every day [40,41].
As matter of fact, our results and a recent monitoring of
personnel working in angiocardiography laboratories in
Iranian Hospitals showed a high frequency of chromo-
some aberrations in cardiologists s and technicians com-
pared to unexposed subjects [68,69].
Taken together, these evidences highlight that the use of a
biological dosimeter could complement the data
Table 4: Cytogenetic studies in hospital workers
Author, year (ref) Exposed Subjects, n Non-exposed 
Subjects, n
Endpoint Results Exposure Correlation with 
dose (Yes/No)
Bigatti et al, 1988, (54) 63 (physicians, nurses 
and technicians)
30 (ward nurses 
and office 
personnel)
CA Positive < legal limit. No
Barquinero et al, 1993, 
(55)
26 (hospital workers) 10 (healthy 
individuals)
CA Positive 1.6–42.71 mSv No
Paz-y-Mino et al, 1995, 
(56)
10 (hospital workers) 10 (healthy 
individuals)
CA Positive 1.84 mSv/year. No
Vera et al, 1997, (57) 20 (medical staff 
working at an X-ray 
department)
20 (general 
population)
CA
MN
Positive <25 mSv/year. No (Major DNA 
damage in subjects 
exposed to both 
ultrasound and X-ray)
Bonassi et al., 1997, (58) 871 (hospital workers 
from 4 laboratories)
617 (healthy 
individuals)
CA Positive Available only 
partially and 
variable.
Yes/No
Rozgaj et al, 1999, (59) 483 (radiologists, 
pneumologists, 
technicians)
160 (healthy 
individuals)
CA Positive <20 mSv/year No
Undeger et al., 1999, (60) 30 (technicians) 30 (nurses, 
technicians, office 
personnel)
Comet Positive 50 mSv/ year. No
Cardoso et al, 2001, (61) 8 (workers in X-rays, 
radiotherapy and 
nuclear medicine 
sectors)
8 (healthy 
individuals)
CA
MN
SCE
Positive 63.2 mSv/life No
Maluf et al, 2001, (62) 22 (hospital workers) 22 (non-exposed 
workers)
MN
Comet
Positive 0.2 – 121. mSv No
Maffei et al, 2002, (63) 37 (physicians, 
technicians)
37 (non-exposed 
workers
MN Negative/ 
Positive
35 mSv /life No
Bozkurt et al, 2003, (64) 16 (nuclear medicine) 16 (non-exposed 
physicians)
SCE Positive 3.39 mSv/year. Yes
Garaj-Vrhovac and 
Kopjar, 2003, (65)
50 (physicians, 25 
technicians, 10 nurses)
50 (healthy 
students and office 
employees)
Comet Positive 0–8.5 mSv/year. No
Maffei et al, 2004, (66) 34 (physicians, 
technicians)
35 (non-exposed 
workers)
CA Positive 1.81–141.77 mSv/
life.
Yes
Zakeri et al., 2004, (67) 71 (cardiologists, 
nurses and technicians)
36 (healthy 
individuals)
CA
MN
Positive 3.0 mSv/year No
Andreassi et al, 2004, 
(67)
31 interventional 
cardiologists
31 clinical 
cardiologists
MN Positive 4 mSv/year No
SCE: sister-chromatid exchange; MN: Micronuclei; CA: Chromosomal aberrations;Cardiovascular Ultrasound 2004, 2:25 http://www.cardiovascularultrasound.com/content/2/1/25
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a) Decrease in exposure to ionizing radiation in hospital radiologists over the most recent decades and b) a similar time-related  reduction in the frequency of chromosome-type aberrations (redrawn from ref. 58) Figure 4
a) Decrease in exposure to ionizing radiation in hospital radiologists over the most recent decades and b) a similar time-related 
reduction in the frequency of chromosome-type aberrations (redrawn from ref. 58)
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obtained by physical dosimetry and reduce the uncertain-
ties of low-dose radiation risk assessment [70]. The analy-
sis of chromosome aberrations is the gold standard
endpoint for radiation biological dosimetry. Limitations
and strengths on biodosimetry have been fully discussed
in the IAEA Report 405 [70]. A possible limitation is the
response to high radiation dose (> 4 Sv) where cell death
and delays in progression through the cycle represents a
pitfall for estimation of acute irradiation particularly
when non-uniform or partial body irradiation have
occurred.
Moreover, the method is laborious, time consuming and
requires expert skills. Scoring of micronuclei has been
proposed as an alternative to conventional chromosome
aberrations analysis, being more sensitive and faster [71].
Although micronuclei method has been improved, inter-
laboratories discrepancies have emphasized the need for
better standardization [53].
However, in many countries the application of cytoge-
netic dosimetry has yet medical-legal recognition, and it is
complementary to physical dosimetry. On the other hand,
the usefulness of biomarkers as early biological effects,
with special concern for the prediction of cancer, has been
recently emphasized [72]. Therefore, the application of
biodosimetry- that measures true cellular injury resulting
from that radiation- could greatly enhance health risk,
identifying susceptible individuals and enhancing the
possibility of preventive measures, especially in
occupational settings with a high volume of radiological
activities (Figure 5).
Illustration of potential use of biomarkers as early predictors of clinical disease Figure 5
Illustration of potential use of biomarkers as early predictors of clinical disease. The evaluation of genetic effects such as chro-
mosomal damage could be used to anticipate delayed health outcomes, providing a greater potential for preventive measures.
Early biological events
Clinical Disease
INDIVIDUAL RISKCardiovascular Ultrasound 2004, 2:25 http://www.cardiovascularultrasound.com/content/2/1/25
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Conclusion
Occupational exposure can occur in cardiological proce-
dures which employ ultrasound and ionizing radiation.
Today, there are no consistent adverse biological effects
on operators caused by exposures to ultrasound. How-
ever, it is clearly necessary to continually monitor both the
potential risks and safety of ultrasound exposure. In con-
trast, exposure to ionizing radiation may result in adverse
health effect on both cardiologists directly and on their
progeny. Although the current risk estimates are clouded
by approximations and extrapolations, most data from
cytogenetic studies have reported an enhanced DNA dam-
age in hospital workers exposed to chronic low doses of
ionizing radiation. The occupational dose of
interventional cardiologists, and electrophysiologists tend
to be higher compared to other medical specialists as a
result of the recent increasing use of interventional tech-
niques. On the other hand, physicians are dramatically
unaware of dose, long-term risks and populations health
impact caused by the use of medical ionizing radiation.
Thus, a major awareness appears to be crucial in order to
improve both one's knowledge on the appropriateness of
protective tools and also in trying to reduce the number of
unnecessary procedures. The use of a biological dosimeter
could be a reliable tool for risk quantification on an indi-
vidual basis.
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